Global Contract Development and Manufacturing Organisations BioCina and NovaCina have announced a strategic merger to create a new biopharmaceutical and small molecule contract manufacturing brand.
BioCina and NovaCina merger aims to bolster the global CDMO industry
January 21, 2025 Australian BiotechLatest Video
New Stories
-
BioCina and NovaCina merger aims to bolster the global CDMO industry
January 21, 2025 - - Australian Biotech -
Australian company Vaxxas named stage winner of US prize to advance vaccine patches
January 20, 2025 - - Australian Biotech -
US issues list of next 15 medicines to face price negotiation power
January 20, 2025 - - Latest News -
Takeda named global top employer for eighth consecutive year
January 20, 2025 - - Latest News -
Stoking 'good' antibodies key to reducing serious bee venom allergic reactions
January 20, 2025 - - Australian Biotech -
'This is a world-leading approach to reduce the impact of RSV on babies'
January 20, 2025 - - Latest News -
New leadership for Boehringer Ingelheim as the company recognised as top employer
January 20, 2025 - - Latest News